ARCHIVES

NIH Limits Increases In Competing Renewals To Biomedical Deflator

This article is from The Cancer Letter archive.

Vol. 17 No. 35 | August 30, 1991

Download PDF Visit The Full Archive

Related Articles

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984

“Comprehensive” Tag For Centers A Poor Choice, Word-Conscious NCI Staff, Committee Feel

February 22, 1974

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

January 14, 1994

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011